Literature DB >> 8355926

Estrogen effects on the urethra: beneficial effects in women with genuine stress incontinence.

G Elia1, A Bergman.   

Abstract

The urethra, which originates from the urogenital sinus, is under the influence of estrogen just like the vagina. The concentration of estrogen receptors in the urethral mucosa is similar to that of the vaginal mucosa. Estrogen deprivation will result in atrophic urethritis and sometimes urinary incontinence, and estrogen replacement therapy may reverse this trend. Estrogens have been shown to increase urethral pressure in up to 30 per cent of women and to significantly improve or cure stress urinary incontinence in many cases. Adding alpha-sympathomimetic drugs to estrogens may further improve symptoms in women with stress incontinence. It seems that vaginal estrogens have more beneficial effect on the urethra, compared with the oral medication, although prospective control studies have not always supported these findings. Overall, it seems that estrogens have beneficial effects on urethral function in women with postmenopausal stress incontinence, although more prospective randomized control studies are needed to assess the effect of estrogens on the lower urinary tract.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8355926     DOI: 10.1097/00006254-199307000-00028

Source DB:  PubMed          Journal:  Obstet Gynecol Surv        ISSN: 0029-7828            Impact factor:   2.347


  9 in total

1.  The effect of ultralow-dose transdermal estradiol on urinary incontinence in postmenopausal women.

Authors:  L Elaine Waetjen; Jeanette S Brown; Eric Vittinghoff; Kristine E Ensrud; JoAnn Pinkerton; Robert Wallace; Judith L Macer; Deborah Grady
Journal:  Obstet Gynecol       Date:  2005-11       Impact factor: 7.661

Review 2.  Estrogen therapy and urinary incontinence: what is the evidence and what do we tell our patients?

Authors:  L Elaine Waetjen; Peter L Dwyer
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2006-03-15

3.  Comparing Serum Follicle-Stimulating Hormone (FSH) Level with Vaginal PH in Women with Menopausal Symptoms.

Authors:  Fatemeh Vahidroodsari; Seddigheh Ayati; Zohreh Yousefi; Shohreh Saeed
Journal:  Oman Med J       Date:  2010-01

4.  Dyspareunia: an unusual presentation of leiomyoma of the bladder.

Authors:  I Y Kim; F Sadeghi; K M Slawin
Journal:  Rev Urol       Date:  2001

5.  Initial experience with the modified vaginal wall sling in the treatment of female stress urinary incontinence.

Authors:  A K Batra; R Mathews; A Lopresti
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  1997

6.  Postmenopausal hormone therapy: does it cause incontinence?

Authors:  Jody E Steinauer; L Elaine Waetjen; Eric Vittinghoff; Leslee L Subak; Stephen B Hulley; Deborah Grady; Feng Lin; Jeanette S Brown
Journal:  Obstet Gynecol       Date:  2005-11       Impact factor: 7.661

7.  Serum estradiol levels are not associated with urinary incontinence in midlife women transitioning through menopause.

Authors:  L Elaine Waetjen; Wesley O Johnson; Guibo Xing; Wen-Ying Feng; Gail A Greendale; Ellen B Gold
Journal:  Menopause       Date:  2011-12       Impact factor: 2.953

8.  Microhematuria in Postmenopausal Women: Adherence to Guidelines in a Tertiary Care Setting.

Authors:  Megan S Bradley; Marcella G Willis-Gray; Cindy L Amundsen; Nazema Y Siddiqui
Journal:  J Urol       Date:  2015-10-30       Impact factor: 7.450

9.  Vaginal pH: A marker for menopause.

Authors:  Subrat Panda; Ananya Das; Ahanthem Santa Singh; Star Pala
Journal:  J Midlife Health       Date:  2014-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.